James Sherblom's most recent trade in Comera Life Sciences Holdings Inc was a trade of 30,906 Stock Option (Right to Purchase) done . Disclosure was reported to the exchange on May 12, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Comera Life Sciences Holdi... | James Sherblom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 30,906 | 30,906 | - | - | Stock Option (Right to Purchase) | |
| Comera Life Sciences Holdi... | James Sherblom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 7,100 | 7,100 | - | - | Stock Option (Right to Purchase) | |
| Comera Life Sciences Holdi... | James Sherblom | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 04 Jan 2023 | 81,081 | 452,244 | - | 1.2 | 99,730 | Common Stock |
| Comera Life Sciences Holdi... | James Sherblom | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Jan 2023 | 81,081 | 81,081 | - | - | Warrant (Right to Buy) |